fda drug shortages semaglutide injection shortage resolved 2025 National Hispanic Medical Association | The federal government is stepping up to stop counterfeit weight-loss drugs. In 2025, bipartisan lawmakers urged stronger enforcement End of Semaglutide Shortage Means

Find a Prime IV location near you and schedule your appointment

Excessive APAP metabolism depletes glutathione and increases N-acetyl-p-benzoquinoneimide (NAPQI) levels, leading to oxidative stress, DNA damage, and cell necrosis in the liver, which in turn leads to liver damage

Genetic counseling and early screenings can also help catch early changes in the skin, improving the chances of successful treatment for melanoma skin cancer

GLP-1 therapy targets appetite signaling optimization, helping your body better recognize fullness and reduce overeating

June 2024 Update: The latest docket report from the Judicial Panel on Multidistrict Litigation (JPML) indicates that there are currently 101 lawsuits filed against the manufacturers of Ozempic and other GLP-1 agonist drugs in the Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation